Restorative and Periodontal Evaluation of Fiber-Reinforced Periodontal Splints

July 27, 2026 updated by: Emre Taşlı

Restorative And Periodontal Evaluation Of The Success Of Fiber-Reinforced Periodontal Splints

Periodontal disease may cause loss of supporting tissues and increased tooth mobility, particularly in the anterior region, leading to functional and esthetic problems. Fiber-reinforced periodontal splinting is used to stabilize mobile teeth and improve patient comfort while preserving natural dentition. The aim of this study is to evaluate the 12-month clinical performance of intracoronal ultra-high molecular weight polyethylene fiber-reinforced periodontal splints in periodontally compromised anterior teeth. Periodontal, restorative, radiographic, and patient-reported outcomes will be assessed at baseline and during follow-up visits at 1, 3, 6, and 12 months.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Periodontal attachment loss may result in pathologic tooth mobility, compromising function, esthetics, and quality of life. Periodontal splinting is commonly used as an adjunctive treatment to stabilize mobile teeth following periodontal therapy. However, evidence regarding the long-term periodontal and restorative performance of intracoronal fiber-reinforced splints remains limited.

This prospective observational cohort study evaluates the clinical performance of intracoronal periodontal splints fabricated with ultra-high molecular weight polyethylene fiber in periodontally compromised anterior teeth. Patients received comprehensive periodontal therapy before splint placement. Clinical periodontal parameters, including probing depth, clinical attachment level, plaque index, gingival index, bleeding on probing, periodontal inflamed surface area (PISA), periodontal epithelial surface area (PESA), radiographic relative bone loss, restorative performance according to modified USPHS criteria, tooth survival, splint survival, and patient satisfaction were evaluated at baseline and after 1, 3, 6, and 12 months.

The findings are expected to provide evidence regarding the short-term clinical effectiveness, periodontal compatibility, restorative performance, and patient-centered outcomes of intracoronal polyethylene fiber-reinforced periodontal splints in the management of periodontally compromised mobile anterior teeth.

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Konya
      • Konya, Konya, Turkey (Türkiye), 42250
        • Selcuk University Faculty of Dentistry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults with periodontitis presenting with pathologic mobility of one or more anterior teeth due to periodontal attachment loss who received intracoronal ultra-high molecular weight polyethylene fiber (Ribbond®) periodontal splinting following active periodontal therapy at the Faculty of Dentistry, Selcuk University.

Description

Inclusion Criteria:

Adults aged 18 years or older. Presence of at least one maxillary or mandibular anterior tooth with pathologic mobility due to periodontal attachment loss requiring intracoronal ultra-high molecular weight polyethylene fiber (Ribbond®) splinting, performed as an adjunct to non-surgical (Phase I) or surgical (Phase II) periodontal therapy, or following completion of periodontal therapy.

Willingness to attend all scheduled follow-up visits during the study period. Provision of written informed consent.

Exclusion Criteria:

Age younger than 18 years. Pregnancy. Splint placement performed for dentoalveolar trauma rather than periodontal attachment loss.

History of chemotherapy, radiotherapy, or immunosuppressive therapy. Temporary splinting intended only for provisional periodontal stabilization. Splinting performed using materials other than ultra-high molecular weight polyethylene fiber (Ribbond®), including wire-composite or composite-only splints.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Fiber-Reinforced Periodontal Splint Group
Participants with periodontally compromised anterior teeth and pathologic tooth mobility who received intracoronal ultra-high molecular weight polyethylene fiber-reinforced periodontal splints following active periodontal therapy.
Device: Intracoronal Fiber-Reinforced Periodontal Splint
Intracoronal fiber-reinforced periodontal splinting using ultra-high molecular weight polyethylene (Ribbond) fibers placed in mobile anterior teeth after completion of active periodontal therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tooth survival
Time Frame: Baseline to 12 months
Number and percentage of splinted teeth remaining in the oral cavity without extraction during the 12-month follow-up period.
Baseline to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale
Time Frame: Baseline, 1 month, 3 months, 6 months, and 12 months
Patient satisfaction assessed using a 10-cm Visual Analog Scale (VAS), with higher scores indicating greater satisfaction.
Baseline, 1 month, 3 months, 6 months, and 12 months
Modified USPHS criteria
Time Frame: Baseline, 1 month, 3 months, 6 months, and 12 months
Clinical evaluation of restorative performance using modified USPHS criteria, including anatomical form, marginal adaptation, marginal discoloration, surface texture, color match, secondary caries, and retention.
Baseline, 1 month, 3 months, 6 months, and 12 months
Relative radiographic bone loss
Time Frame: Baseline, 6 months, and 12 months
Relative radiographic bone loss (RBL) assessed on standardized periapical radiographs during follow-up.
Baseline, 6 months, and 12 months
Probing Pocket Depth (PPD)
Time Frame: Baseline, 6 months, and 12 months
Mean probing pocket depth measured in millimeters using a periodontal probe at six sites per tooth.
Baseline, 6 months, and 12 months
Clinical Attachment Level (CAL)
Time Frame: Baseline, 6 months, and 12 months
Mean clinical attachment level measured in millimeters using a periodontal probe at six sites per tooth.
Baseline, 6 months, and 12 months
Plaque Index (PI)
Time Frame: Baseline, 6 months, and 12 months
Plaque accumulation assessed using the Silness and Löe Plaque Index.
Baseline, 6 months, and 12 months
Gingival Index (GI)
Time Frame: Baseline, 6 months, and 12 months
Gingival inflammation assessed using the Löe and Silness Gingival Index.
Baseline, 6 months, and 12 months
Bleeding on Probing (BOP)
Time Frame: Baseline, 6 months, and 12 months
Bleeding on probing recorded as the percentage of sites exhibiting bleeding after periodontal probing.
Baseline, 6 months, and 12 months
Periodontal Inflamed Surface Area (PISA)
Time Frame: Baseline, 6 months, and 12 months
Periodontal inflamed surface area calculated from periodontal clinical measurements according to the validated PISA method.
Baseline, 6 months, and 12 months
Periodontal Epithelial Surface Area (PESA)
Time Frame: Baseline, 6 months, and 12 months
Periodontal epithelial surface area calculated from periodontal clinical measurements according to the validated PESA method.
Baseline, 6 months, and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Emre Taşlı

Investigators

  • Principal Investigator: Emine Elif Mutafcılar Velioğlu, DDS, Selcuk University Faculty of Dentistry

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

July 21, 2026

First Submitted That Met QC Criteria

July 27, 2026

First Posted (Actual)

July 28, 2026

Study Record Updates

Last Update Posted (Actual)

July 28, 2026

Last Update Submitted That Met QC Criteria

July 27, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SU-ET-2024-28

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe